ScinoPharm Taiwan Ltd banner

ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 21.9 TWD 1.15% Market Closed
Market Cap: NT$17.3B

Wall Street
Price Targets

Price Targets Summary
ScinoPharm Taiwan Ltd

Wall Street analysts forecast ScinoPharm Taiwan Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ScinoPharm Taiwan Ltd is 27.03 TWD with a low forecast of 26.77 TWD and a high forecast of 27.83 TWD.

Lowest
Price Target
26.77 TWD
22% Upside
Average
Price Target
27.03 TWD
23% Upside
Highest
Price Target
27.83 TWD
27% Upside
ScinoPharm Taiwan Ltd Competitors:
Price Targets

Revenue
Forecast

-1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's revenue is -1%. The projected CAGR for the next 2 years is 4%.

Operating Income
Forecast

-9% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-9% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's operating income is -9%. The projected CAGR for the next 2 years is 20%.

Net Income
Forecast

-8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
-8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's net income is -8%. The projected CAGR for the next 2 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ScinoPharm Taiwan Ltd's stock price target?
Price Target
27.03 TWD

According to Wall Street analysts, the average 1-year price target for ScinoPharm Taiwan Ltd is 27.03 TWD with a low forecast of 26.77 TWD and a high forecast of 27.83 TWD.

What is ScinoPharm Taiwan Ltd's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's revenue is -1%. The projected CAGR for the next 2 years is 4%.

What is ScinoPharm Taiwan Ltd's Operating Income forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's operating income is -9%. The projected CAGR for the next 2 years is 20%.

What is ScinoPharm Taiwan Ltd's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for ScinoPharm Taiwan Ltd's net income is -8%. The projected CAGR for the next 2 years is 12%.

Back to Top